Treatment of High-Risk Neuroblastoma in a Southeast Asian Hub of Medical Tourism

被引：0
|
作者：
Lee, A. [1 ]
Chui, C. H. [2 ]
Aung, L. [1 ]
Wong, W. [3 ]
机构：
[1] Mt Elizabeth Hosp, Childrens Haematol & Canc Ctr, Singapore, Singapore
[2] Mt Elizabeth Med Ctr, Surg Ctr Children, Singapore, Singapore
[3] Univ Hong Kong, Dept Paediat & Adolescent Med, Hong Kong, Hong Kong, Peoples R China
来源：
PEDIATRIC BLOOD & CANCER | 2018年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-375
引用
收藏
页码：S263 / S263
页数：1
相关论文
共 50 条
  • [31] Dinutuximab: A Review in High-Risk Neuroblastoma
    Hoy, Sheridan M.
    TARGETED ONCOLOGY, 2016, 11 (02) : 247 - 253
  • [32] The genetic landscape of high-risk neuroblastoma
    Pugh, Trevor J.
    Morozova, Olena
    Attiyeh, Edward F.
    Asgharzadeh, Shahab
    Wei, Jun S.
    Auclair, Daniel
    Carter, Scott L.
    Cibulskis, Kristian
    Hanna, Megan
    Kiezun, Adam
    Kim, Jaegil
    Lawrence, Michael S.
    Lichenstein, Lee
    McKenna, Aaron
    Pedamallu, Chandra Sekhar
    Ramos, Alex H.
    Shefler, Erica
    Sivachenko, Andrey
    Sougnez, Carrie
    Stewart, Chip
    Ally, Adrian
    Birol, Inanc
    Chiu, Readman
    Corbett, Richard D.
    Hirst, Martin
    Jackman, Shaun D.
    Kamoh, Baljit
    Khodabakshi, Alireza Hadj
    Krzywinski, Martin
    Lo, Allan
    Moore, Richard A.
    Mungall, Karen L.
    Qian, Jenny
    Tam, Angela
    Thiessen, Nina
    Zhao, Yongjun
    Cole, Kristina A.
    Diamond, Maura
    Diskin, Sharon J.
    Mosse, Yael P.
    Wood, Andrew C.
    Ji, Lingyun
    Sposto, Richard
    Badgett, Thomas
    London, Wendy B.
    Moyer, Yvonne
    Gastier-Foster, Julie M.
    Smith, Malcolm A.
    Auvil, Jaime M. Guidry
    Gerhard, Daniela S.
    NATURE GENETICS, 2013, 45 (03) : 279 - 284
  • [33] Immunocombination therapy for high-risk neuroblastoma
    Kroesen, Michiel
    Lindau, Dennis
    Hoogerbrugge, Peter
    Adema, Gosse J.
    IMMUNOTHERAPY, 2012, 4 (02) : 163 - 174
  • [34] A Safer Regimen for High-Risk Neuroblastoma
    Felix, Carolyn A.
    PEDIATRIC BLOOD & CANCER, 2009, 53 (01) : 3 - 6
  • [35] The Role of Surgery in High-risk Neuroblastoma
    Ryan, Anne L.
    Akinkuotu, Adesola
    Pierro, Agostino
    Morgenstern, Daniel A.
    Irwin, Meredith S.
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2020, 42 (01) : 1 - 7
  • [36] Evolving treatments in high-risk neuroblastoma
    Kumar, Abhinav
    Rocke, John P. J.
    Kumar, B. Nirmal
    EXPERT OPINION ON ORPHAN DRUGS, 2020, 8 (12): : 497 - 506
  • [37] Outcome of children with high-risk neuroblastoma
    Fluchel, M
    Hawkins, DS
    Felgenhauer, J
    Douglas, JJ
    Sanders, JE
    Park, JR
    PEDIATRIC RESEARCH, 2003, 53 (04) : 300A - 301A
  • [38] The Influence of Sarcopenia on High-Risk Neuroblastoma
    Kawakubo, Naonori
    Kinoshita, Yoshiaki
    Souzaki, Ryota
    Koga, Yuhki
    Oba, Utako
    Ohga, Shouichi
    Taguchi, Tomoaki
    JOURNAL OF SURGICAL RESEARCH, 2019, 236 : 101 - 105
  • [39] The Influence of Sarcopenia on High-Risk Neuroblastoma
    Isiklar, Aysun Dauti
    Safer, Umut
    Safer, Vildan Binay
    JOURNAL OF SURGICAL RESEARCH, 2019, 239 : 173 - 173
  • [40] PROTEOMIC ANALYSIS OF HIGH-RISK NEUROBLASTOMA
    Ho, M.
    Chua, Y. W.
    Kam, S. Y.
    Loh, A. H. P.
    Chang, K. T. E.
    Chua, J. H. Y.
    Chen, Y.
    Soh, S. Y.
    Lai, S. H.
    Hennessy, T.
    Kon, O. L.
    PEDIATRIC BLOOD & CANCER, 2013, 60 : 117 - 118
12345